93 results
8-K
EX-99.1
INLB
Item 9 Labs Corp.
30 Nov 22
Item 9 Labs Corp. Appoints Mike Weinberger to CEO Ahead of Approaching Transformational Acquisition
9:00am
the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties
8-K
EX-10.3
INLB
Item 9 Labs Corp.
11 Oct 22
Unregistered Sales of Equity Securities
12:38pm
to initiate involuntary bankruptcy or insolvency proceedings.
(h) Absence of Litigation. There is no action, suit, proceeding, inquiry … , the prevailing party shall be permitted to receive reasonable attorney fees and other litigation costs associated with such dispute. The term
8-K
EX-10.2
INLB
Item 9 Labs Corp.
11 Oct 22
Unregistered Sales of Equity Securities
12:38pm
of the attorneys’ fees and expenses paid by such prevailing party in connection with the litigation and/or dispute without reduction or apportionment
8-K
EX-10.1
INLB
Item 9 Labs Corp.
11 Oct 22
Unregistered Sales of Equity Securities
12:38pm
to such claim or litigation. Following indemnification as provided for hereunder, the indemnifying party shall be subrogated to all rights of the Indemnified … on our review of the Commission’s “Stop Orders” web page (http://sec.gov/litigation/stoporders.shtml), that any stop order suspending the Registration
8-K
EX-99.1
INLB
Item 9 Labs Corp.
16 Aug 22
Regulation FD Disclosure
8:01am
provisions of the Private Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties, including, but not limited to, risks
8-K
EX-2.1
4ntwj264qiooqowxhh5t
24 May 22
Item 9 Labs Corp. Signs Definitive Agreement to Acquire Sessions Cannabis, One of Canada’s Largest Cannabis Retail Franchisors
5:17pm
8-K
EX-99.1
zim2c7rx4 gvrwfj7
24 May 22
Item 9 Labs Corp. Signs Definitive Agreement to Acquire Sessions Cannabis, One of Canada’s Largest Cannabis Retail Franchisors
5:17pm
8-K
EX-99.1
2bu5xquc irbl
16 May 22
Item 9 Labs Corp. Announces Second Quarter FY 2022 Financial Results with Revenue Growth of 9% to $6.6 Million
12:00am
8-K
EX-99.1
5bsxag8d puzu2wfv20w
17 Mar 22
Entry into a Material Definitive Agreement
5:47pm
8-K
EX-99.1
6ke64nryhm52vl8t cl
4 Mar 22
Item 9 Labs Corp. Closes Acquisition of Adams County, Colorado Dispensary
1:55pm
8-K
EX-99.1
qnufhdx
2 Mar 22
Item 9 Labs Corp. Strengthens Board of Directors with Appointment of Massage Heights Founder
10:13am
8-K
EX-99.1
a6kbo4
15 Feb 22
Item 9 Labs Corp. Announces First Quarter FY 2022 Financial Results with Revenue Growth of 104% to $6.2 Million
9:33am
8-K
EX-99.1
467267 3uxl4p
18 Jan 22
Item 9 Labs Corp. Reports Record FY 2021 Annual Financial Results with Revenue Growth of 170% to $21.9 Million Revenue
9:30am
8-K
EX-2.1
3cy0vqi dec
7 Oct 21
Item 9 Labs Corp. to Acquire Colorado Dispensary, Kickstarts National Acquisition Growth Plan
2:25pm
8-K
EX-99.1
zlemwzc
7 Oct 21
Item 9 Labs Corp. to Acquire Colorado Dispensary, Kickstarts National Acquisition Growth Plan
2:25pm
8-K/A
EX-99.1
w1piy4p9tzy9y za4iz5
29 Sep 21
Financial Statements and Exhibits
9:20pm
8-K
EX-10.2
uc0teoobpln5ny qx
31 Aug 21
Entry into a Material Definitive Agreement
3:56pm
8-K
EX-10.1
59gjx5
31 Aug 21
Entry into a Material Definitive Agreement
3:56pm
8-K
EX-99.1
swoltb23kq78x4hg2iv
31 Aug 21
Entry into a Material Definitive Agreement
3:56pm